Focused Ultrasound Driven Drug Release From Theranostic Nanoparticles For The treatment Of Pancreatic Cancer

Project Name: Focused Ultrasound Driven Drug Release From Theranostic Nanoparticles For The treatment Of Pancreatic Cancer
Status: Closed
Primary Site: Froedtert & the Medical College of Wisconsin
Sponsor Organization: Focused Ultrasound Foundation
Funded Date: Jan 24, 2018
Funding Program: Research Award
Funding Period: Jan 24, 2018 - Jan 24, 2019
Amount Awarded: $100,000.00
Category: Pancreatic tumors

Abstract

Pancreatic cancer is one of the deadliest cancers and is known for being chemoresistant. Despite utilizing new combinations of drugs and radiation, outcomes remain dismal while average incidence and death rates remain unchanged. Pancreatic cancer is recalcitrant to treatment because of the difficulties in transporting drugs to tumor sites due to unique physiological barriers. Therefore, our approach is to deliver drugs site selectively and to track delivery in real time. Furthermore, we will use focused ultrasound (FUS) to trigger drug release, which will increase ablation capabilities of FUS alone. This will therefore allow tissue heating to be combined with high local drug concentrations, which will kill tumor cells in a preclinical model

Contact Roles

Reports

No reports found.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email